Soluble Fms-Like Tyrosin Kinase-1 and Placental Growth Factor Biomarkers Integrated for Predictability of Preeclampsia
• 2023
Publication Information
Authors
Mahmoud Abosrea*, Ahmed Mousad* and Asmaa Elfallah
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: Biomarkers in diagnostic and prognostic approaches in obstetric research efforts are gaining a global interest however the sensitivity and specificity of those biomarkers are considered an issue of research debate
Aim: To investigate usefulness and reliability of implementing the usage of sFlt-1/PIGF ratio for predictability of the presence or absence of preeclampsia development.
Methodology: A cohort and randomized research study was conducted on 50 pregnant cases, the course of pregnancy was observed extensively in randomly selected pregnant women. Personal and history data, personal habits, the course and pregnancy clinical outcome was recorded. Research study subjects were equally categorized in two groups as follows: the control group and the preeclampsia group. Serum levels of sFlt-1 and PIGF in obtained samples was determined retrospectively by usage of Elecsys assays on an electrochemiluminescence immunoassay platform and implemented to calculate the sFlt-1/PIGF ratio.
Result: Comparative statistical analysis of soluble fms-like tyrosine kinase 1, placental growth factor and sFLT/PlGF ratio among term and preterm preeclampsia cases showed highly statistical significant difference between term and preterm research categories of preeclampsia cases as regards soluble fms-like tyrosine kinase 1 (pg/ml) 24-28 GA, 28-31 GA (p values
Aim: To investigate usefulness and reliability of implementing the usage of sFlt-1/PIGF ratio for predictability of the presence or absence of preeclampsia development.
Methodology: A cohort and randomized research study was conducted on 50 pregnant cases, the course of pregnancy was observed extensively in randomly selected pregnant women. Personal and history data, personal habits, the course and pregnancy clinical outcome was recorded. Research study subjects were equally categorized in two groups as follows: the control group and the preeclampsia group. Serum levels of sFlt-1 and PIGF in obtained samples was determined retrospectively by usage of Elecsys assays on an electrochemiluminescence immunoassay platform and implemented to calculate the sFlt-1/PIGF ratio.
Result: Comparative statistical analysis of soluble fms-like tyrosine kinase 1, placental growth factor and sFLT/PlGF ratio among term and preterm preeclampsia cases showed highly statistical significant difference between term and preterm research categories of preeclampsia cases as regards soluble fms-like tyrosine kinase 1 (pg/ml) 24-28 GA, 28-31 GA (p values
Staff Members - Benha University